Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Staphysagria is a homeopathic remedy derived from the seeds of the *Delphinium staphisagria* plant. In a clinical trial context led by Shaare Zedek Medical Center (NCT02072473), it was evaluated in a 30C potency, often in combination with *Bellis perennis*, for its potential to improve post-operative recovery in women undergoing elective Cesarean section. Homeopathic Staphysagria is traditionally indicated for the treatment of clean-cut surgical incisions and the management of associated post-surgical pain and emotional distress. The remedy is typically administered orally as sublingual pellets. Like other homeopathic preparations, its mechanism of action is based on the principle of 'like cures like' and extreme dilution, and it does not have a recognized biochemical target in conventional pharmacology.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on staphysagria.